Skip to main content Accessibility help

We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.

Close cookie message
×
Hostname: page-component-77c89778f8-cnmwb Total loading time: 0 Render date: 2024-07-19T03:05:01.704Z Has data issue: false hasContentIssue false

13b - Lifespan aspects of brain tumors

from Section II - Disorders

Published online by Cambridge University Press:  07 May 2010

By
Celiane Rey-Casserly
Edited by
Jacobus Donders  and
Scott J. Hunter
Jacobus Donders
Affiliation:
Mary Free Bed Rehabilitation Hospital
Scott J. Hunter
Affiliation:
University of Chicago
Get access

Summary

Introduction

This chapter will focus on brain tumors across the lifespan with an emphasis on the contribution of developmental factors to incidence, presentation, treatment, and outcome. The epidemiology, classification, signs and symptoms, and major types of treatment of brain tumors are reviewed for children and adults. Neuropsychological outcomes and management strategies are then described for each of these populations separately.

Epidemiology

It is estimated that over 51,000 new cases of primary brain tumors were diagnosed in the USA in 2007, including over 3700 new cases of childhood primary brain tumors [1]. Brain tumors are the most common solid tumor of childhood and a leading cause of cancer-related death; in adults, they constitute the sixth most common neoplasm [2, 3]. The incidence of different types of tumors varies by age group, histology, and location. Survival rates also vary significantly among age groups [Table 13b.1]. Primary brain tumors develop as a consequence of genetic, molecular, or cytogenetic errors that allow cells to proliferate and turn off mechanisms that regulate cell growth [4]. Investigation into the molecular basis of tumorigenesis is an active area of neuroscience research though identification of specific causes of brain tumors has remained elusive, particularly in the case of childhood tumors. Primary risk factors for brain tumors include certain hereditary syndromes associated with mutations of tumor suppressor genes (neurofibromatosis Type 1 and Type 2, Turcot syndrome, nevoid basal cell carcinoma (Gorlin) syndrome, tuberous sclerosis, and Li-Fraumeni syndrome) and exposure to ionizing radiation.

Type
Chapter
Information
Principles and Practice of Lifespan Developmental Neuropsychology , pp. 393 - 408
Publisher: Cambridge University Press
Print publication year: 2010

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

,CBTRUS. Statistical Report: Primary Brain Tumors in the United States, 2000–2004: Central Brain Tumor Registry of the United States; 2008.
Baldwin, RT, Preston-Martin, S. Epidemiology of brain tumors in childhood – a review. Toxicol Appl Pharmacol 2004;199(2):118–31.CrossRefGoogle ScholarPubMed
Rees, J.Neurological oncology. Medicine (Baltimore) 2004;32(10):75–9.CrossRefGoogle Scholar
Wrensch, M, Minn, Y, Chew, T, Bondy, M, Berger, MS. Epidemiology of primary brain tumors: current concepts and review of the literature. Neuro Oncol 2002;4(4):278–99.CrossRefGoogle ScholarPubMed
Blaney, SM, Kun, , Hunter, J, Rorke-Adams, LB, Lau, C, Strother, D, et al. Tumors of the central nervous system. In Pizzo, PA, Poplack, DG, eds. Principles and Practice of Pediatric Oncology, 5th edn. Philadelphia: Lippincott Williams & Wilkins; 2006: 787–863.Google Scholar
Buckner, JC, Brown, PD, O'Neill, BP, Meyer, FB, Wetmore, CJ, Uhm, JH. Central nervous system tumors. Mayo Clin Proc 2007;82(10):1271–86.CrossRefGoogle ScholarPubMed
Louis, DN, Ohgaki, H, Wiestler, OD, Cavenee, WK, eds. WHO Classification of tumours of the central nervous system. Lyon: IARC; 2007.PubMed
Louis, DN, Ohgaki, H, Wiestler, OD, Cavenee, WK, Burger, PC, Jouvet, A, et al. The 2007 WHO classification of tumours of the central nervous system. Acta Neuropathol 2007;114(2):97–109.CrossRefGoogle ScholarPubMed
Nakamura, M, Shimada, K, Ishida, E, Higuchi, T, Nakase, H, Sakaki, T, et al. Molecular pathogenesis of pediatric astrocytic tumors. Neuro Oncol 2007;9(2):113–23.CrossRefGoogle ScholarPubMed
Grimmer, MR, Weiss, WA. Childhood tumors of the nervous system as disorders of normal development. Curr Opin Pediatr 2006;18(6):634–8.CrossRefGoogle ScholarPubMed
Bannykh, S. Pathology and classification of tumors of the nervous system. In Baehring, JM, Peipmeier, JM, eds. Brain Tumors: Practical Guide to Diagnosis and Treatment. New York: Informa Health Care; 2007: 133–58.Google Scholar
Partap, S, Fisher, PG. Update on new treatments and developments in childhood brain tumors. Curr Opin Pediatr 2007;19(6):670–4.CrossRefGoogle ScholarPubMed
Riefenberger, G, Blumcke, I, Pietsch, T, Paulus, W. Pathology and classification of tumors of the nervous system. In Tonn, JC, Westphal, M, Rutka, JT, Grossman, SA, eds. Neuro-Oncology of CNS Tumors. Berlin: Springer; 2006: 3–72.CrossRefGoogle Scholar
Tonn, JC, Westphal, M, Rutka, JT, Grossman, SA, eds. Neuro-Oncology of CNS Tumors. Berlin: Springer; 2006.CrossRef
Bent, M. Astrocytic tumors. In Baehring, JM, Piepmeier, JM, eds. Brain Tumors: Practical Guide to Diagnosis and Treatment. New York: Informa Health Care; 2007: 159–92.
Packer, RJ, MacDonald, T, Vezina, G. Central nervous system tumors. Pediatr Clin North Am 2008;55(1):121.CrossRefGoogle ScholarPubMed
Westphal, M, Lamszus, K, Tonn, JC. Meningiomas and meningeal tumors. In Tonn, JC, Westphal, M, Rutka, JT, Grossman, SA, eds. Neuro-Oncology of CNS Tumors. Berlin: Springer; 2006: 82–101.Google Scholar
Wen, PY, Kesari, S. Malignant gliomas in adults. N Engl J Med. 2008;359(5):492–507.CrossRefGoogle ScholarPubMed
Black, P, Hogan, SH. Living with a Brain Tumor. New York: Henry Holt; 2006.Google Scholar
Reulecke, BC, Erker, CG, Fiedler, BJ, Niederstadt, T-U, Kurlemann, G. Brain tumors in children: Initial symptoms and their influence on the time span between symptom onset and diagnosis. J Child Neurol 2008;23(2):178–83.CrossRefGoogle ScholarPubMed
Hoff, K, Kieffer, V, Habrand, JL, Kalifa, C, Dellatolas, G, Grill, J. Impairment of intellectual functions after surgery and posterior fossa irradiation in children with ependymoma is related to age and neurologic complications. BMC Cancer 2008;8:15.Google Scholar
Crawford, JR, MacDonald, TJ, Packer, RJ. Medulloblastoma in childhood: new biological advances. Lancet Neurol 2007;6(12):1073–85.CrossRefGoogle ScholarPubMed
Dennis, M, Spiegler, BJ, Riva, D, MacGregor, DL. Neuropsychological outcome. In Walker, D, Perilongo, G, Punt, CJA, Taylor, RE, eds. Brain and Spinal Tumors of Childhood. London: Arnold; 2004: 213–27.CrossRefGoogle Scholar
Pollack, IF. Neurobehavioral abnormalities after posterior fossa surgery in children. Int Rev Psychiatry 2001;13(4):302–12.CrossRefGoogle Scholar
Robertson, PL, Muraszko, KM, Holmes, EJ, Sposto, R, Packer, RJ, Gajjar, A, et al. Incidence and severity of postoperative cerebellar mutism syndrome in children with medulloblastoma: a prospective study by the Children's Oncology Group. J Neurosurg 2006;105(6 Suppl):444–51.Google ScholarPubMed
Huber, JF, Bradley, K, Spiegler, BJ, Dennis, M. Long-term effects of transient cerebellar mutism after cerebellar astrocytoma or medulloblastoma tumor resection in childhood. Childs Nerv Syst 2006;22(2 (Print)):132–8.CrossRefGoogle ScholarPubMed
Knisely, JPS. Principles of radiation therapy. In Baehring, JM, Piepmeier, JM, eds. Brain Tumors: Practical Guide to Diagnosis and Treatment. New York: Informa Health Care; 2007: 17–42.Google Scholar
Yock, TI, Tarbell, NJ. Technology insight: proton beam radiotherapy for treatment in pediatric brain tumors. Nat Clin Pract Oncol. 2004;1(2):97–103.Google ScholarPubMed
Merchant, TE, Hua, C, Shukla, H, Ying, X, Nill, S, Oelfke, U. Proton versus photon radiotherapy for common pediatric brain tumors: comparison of models of dose characteristics and their relationship to cognitive function. Pediatr Blood Cancer 2008;51(1):110–7.CrossRefGoogle ScholarPubMed
Kaye, DL. Pediatric brain tumors. In Coffey, CE, Brumback, RA, eds. Pediatric Neuropsychiatry. Philadelphia: Lippincott Williams & Wilkins; 2006:565–86.Google Scholar
Sarkissian, V. The sequelae of cranial irradiation on human cognition. Neurosci Lett 2005;382(1–2):118–23.CrossRefGoogle ScholarPubMed
Monje, ML, Mizumatsu, S, Fike, JR, Palmer, TD. Irradiation induces neural precursor-cell dysfunction. Nat Med 2002;8(9):955–62.CrossRefGoogle ScholarPubMed
Brandes, AA, Compostella, A, Blatt, V, Tosoni, A. Glioblastoma in the elderly: current and future trends. Crit Rev Oncol Hematol 2006;60(3):256–66.CrossRefGoogle ScholarPubMed
Gilbert, MR, Armstrong, TS. Management of patients with newly diagnosed malignant primary brain tumors with a focus on the evolving role of temozolomide. Ther Clin Risk Manag 2007;3(6):1027–33.Google ScholarPubMed
Packer, RJ, Goldwein, J, Nicholson, HS, Vezina, LG, Allen, JC, Ris, MD, et al. Treatment of children with medulloblastomas with reduced-dose craniospinal radiation therapy and adjuvant chemotherapy: a Children's Cancer Group Study. J Clin Oncol 1999;17(7):2127–36.CrossRefGoogle ScholarPubMed
Marachelian, A, Butturini, A, Finlay, J. Myeloablative chemotherapy with autologous hematopoietic progenitor cell rescue for childhood central nervous system tumors. Bone Marrow Transplant 2008;41(2):167–72.CrossRefGoogle ScholarPubMed
Ali-Osman, F, Friedman, HS, Antoun, GR, Reardon, D, Bigner, DD, Buolamwini, JK. Rational design and development of targeted brain tumor therapeutics. In Ail-Osman, F, ed. Contemporary Cancer Research: Brain Tumors. Totowa, NJ: Humana Press; 2005: 359–81.Google Scholar
Ahles, TA, Saykin, AJ. Candidate mechanisms for chemotherapy-induced cognitive changes. Nat Rev Cancer 2007;7(3):192–201.CrossRefGoogle ScholarPubMed
Dietrich, J, Han, R, Yang, Y, Mayer-Proschel, M, Noble, M. CNS progenitor cells and oligodendrocytes are targets of chemotherapeutic agents in vitro and in vivo. J Biol 2006;5(7):22.CrossRefGoogle ScholarPubMed
Mrakotsky, C, Waber, D. Chemotherapy agents for treatment of acute lymphoblastic leukemia. In Bellinger, D, ed. Human Developmental Neurotoxicology. New York: Taylor and Francis; 2006: 131–47.Google Scholar
Butler, RW, Haser, JK. Neurocognitive effects of treatment for childhood cancer. Ment Retard Dev Disabil Res Rev 2006;12(3):184–91.CrossRefGoogle ScholarPubMed
Hoppe-Hirsch, E, Renier, D, Lellouch-Tubiana, A, Sainte-Rose, C, Pierre-Kahn, A, Hirsch, JF. Medulloblastoma in childhood: progressive intellectual deterioration. Childs Nerv Syst 1990;6(2):60–5.CrossRefGoogle ScholarPubMed
Mulhern, RK, Merchant, TE, Gajjar, A, Reddick, WE, Kun, . Late neurocognitive sequelae in survivors of brain tumours in childhood. Lancet Oncol 2004;5(7 (Print)):399–408.CrossRefGoogle ScholarPubMed
Reimers, TS, Ehrenfels, S, Mortensen, EL, Schmiegelow, M, Sonderkaer, S, Carstensen, H, et al. Cognitive deficits in long-term survivors of childhood brain tumors: Identification of predictive factors. Med Pediatr Oncol 2003;40(1):26–34.CrossRefGoogle ScholarPubMed
Roncadin, C, Dennis, M, Greenberg, ML, Spiegler, BJ. Adverse medical events associated with childhood cerebellar astrocytomas and medulloblastomas: natural history and relation to very long-term neurobehavioral outcome. Childs Nerv Syst 2008;24(9):995–1002.CrossRefGoogle ScholarPubMed
Stiles, J. The Fundamentals of Brain Development: Integrating Nature and Nurture. Cambridge, MA: Harvard University Press; 2008.Google Scholar
Ullrich, NJ. Inherited disorders as a risk factor and predictor of neurodevelopmental outcome in pediatric cancer. Dev Disabil Res Rev 2008;14(3):229–37.CrossRefGoogle ScholarPubMed
Maddrey, AM, Bergeron, JA, Lombardo, ER, McDonald, NK, Mulne, AF, Barenberg, PD, et al. Neuropsychological performance and quality of life of 10 year survivors of childhood medulloblastoma. J Neurooncol 2005;72(3):245–53.CrossRefGoogle ScholarPubMed
Fouladi, M, Gilger, E, Kocak, M, Wallace, D, Buchanan, G, Reeves, C, et al. Intellectual and functional outcome of children 3 years old or younger who have CNS malignancies. J Clin Oncol 2005;23(28):7152–60.CrossRefGoogle ScholarPubMed
Reimers, TS, Mortensen, EL, Schmiegelow, K. Memory deficits in long-term survivors of childhood brain tumors may primarily reflect general cognitive dysfunctions. Pediatr Blood Cancer 2007;48(2):205–12.CrossRefGoogle ScholarPubMed
King, TZ, Fennell, EB, Williams, L, Algina, J, Boggs, S, Crosson, B, et al. Verbal memory abilities of children with brain tumors. Child Neuropsychol 2004;10(2):76–88.CrossRefGoogle ScholarPubMed
Carpentieri, SC, Waber, DP, Scott, RM, Goumnerova, LC, Kieran, MW, Cohen, , et al. Memory deficits among children with craniopharyngiomas. Neurosurgery 2001;49(5):1053–7; discussion 7–8.Google ScholarPubMed
Sands, SA, Milner, JS, Goldberg, J, Mukhi, V, Moliterno, JA, Maxfield, C, et al. Quality of life and behavioral follow-up study of pediatric survivors of craniopharyngioma. J Neurosurg 2005;103(4 Suppl):302–11.Google ScholarPubMed
Beebe, DW, Ris, MD, Armstrong, FD, Fontanesi, J, Mulhern, RK, Holmes, E, et al. Cognitive and adaptive outcome in low-grade pediatric cerebellar astrocytomas: evidence of diminished cognitive and adaptive functioning in National Collaborative Research Studies (CCG 9891/POG 9130). J Clin Oncol 2005;23(22):5198–204.CrossRefGoogle Scholar
Dum, RP, Strick, PL. An unfolded map of the cerebellar dentate nucleus and its projections to the cerebral cortex. J Neurophysiol 2003;89(1):634–9.CrossRefGoogle ScholarPubMed
Middleton, FA, Strick, PL. The cerebellum: an overview. Trends Neurosci 1998;21(9):367–9.CrossRefGoogle ScholarPubMed
Scotting, PJ, Appleby, VJ. Neuroembryology. In Walker, DA, Perilongo, G, Punt, JAG, Taylor, RE, eds. Brain and Spinal Turmors of Childhood. London: Arnold; 2004: 50–66.CrossRefGoogle Scholar
Ris, MD, Packer, RJ, Goldwein, J, Jones-Wallace, D, Boyett, JM. Intellectual outcome after reduced-dose radiation therapy plus adjuvant chemotherapy for medulloblastoma: a Children's Cancer Group study. J Clin Oncol 2001;19(15):3470–6.CrossRefGoogle ScholarPubMed
Spiegler, BJ, Bouffet, E, Greenberg, ML, Rutka, JT, Mabbott, DJ. Change in neurocognitive functioning after treatment with cranial radiation in childhood. J Clin Oncol 2004;22(4):706–13.CrossRefGoogle ScholarPubMed
Riva, D, Pantaleoni, C, Devoti, M, Saletti, V, Nichelli, F, Giorgi, C. Late neuropsychological and behavioural outcome of children surgically treated for craniopharyngioma. Childs Nerv Syst 1998;14:170–84.CrossRefGoogle ScholarPubMed
Schmahmann, JD, Sherman, JC. The cerebellar cognitive affective syndrome. Brain 1998;121 (Pt 4):561–79.CrossRefGoogle ScholarPubMed
Cantelmi, D, Schweizer, TA, Cusimano, MD. Role of the cerebellum in the neurocognitive sequelae of treatment of tumours of the posterior fossa: an update. Lancet Oncol 2008;9(6):569–76.CrossRefGoogle ScholarPubMed
Mulhern, RK, White, HA, Glass, JO, Kun, , Leigh, L, Thompson, SJ, et al. Attentional functioning and white matter integrity among survivors of malignant brain tumors of childhood. J Int Neuropsychol Soc 2004;10(2):180–9.CrossRefGoogle ScholarPubMed
Qiu, D, Kwong, DL, Chan, GC, Leung, LH, Khong, PL. Diffusion tensor magnetic resonance imaging finding of discrepant fractional anisotropy between the frontal and parietal lobes after whole-brain irradiation in childhood medulloblastoma survivors: reflection of regional white matter radiosensitivity?Int J Radiat Oncol Biol Phys 2007;69(3):846–51.CrossRefGoogle ScholarPubMed
Merchant, TE, Kiehna, EN, Miles, MA, Zhu, J, Xiong, X, Mulhern, RK. Acute effects of irradiation on cognition: changes in attention on a computerized continuous performance test during radiotherapy in pediatric patients with localized primary brain tumors. Int J Radiat Oncol Biol Phys 2002;53(5):1271–8.CrossRefGoogle ScholarPubMed
Patel, SK, Lai-Yates, JJ, Anderson, JW, Katz, ER. Attention dysfunction and parent reporting in children with brain tumors. Pediatr Blood Cancer 2007;49(7):970–4.CrossRefGoogle ScholarPubMed
Reddick, WE, White, HA, Glass, JO, Wheeler, GC, Thompson, SJ, Gajjar, A, et al. Developmental model relating white matter volume to neurocognitive deficits in pediatric brain tumor survivors. Cancer 2003;97(10):2512–9.CrossRefGoogle ScholarPubMed
Kiehna, EN, Mulhern, RK, Li, C, Xiong, X, Merchant, TE. Changes in attentional performance of children and young adults with localized primary brain tumors after conformal radiation therapy. J Clin Oncol 2006;24(33):5283–90.CrossRefGoogle Scholar
Papazoglou, A, King, TZ, Morris, RD, Morris, MK, Krawiecki, NS. Attention mediates radiation's impact on daily living skills in children treated for brain tumors. Pediatr Blood Cancer 2008;50(6):1253–7.CrossRefGoogle ScholarPubMed
Conklin, HM, Luciana, M, Hooper, CJ, Yarger, RS. Working memory performance in typically developing children and adolescents. Dev Neuropsychol 2007;31(1):103–28.CrossRefGoogle ScholarPubMed
Mabbott, DJ, Penkman, L, Witol, A, Strother, D, Bouffet, E. Core neurocognitive functions in children treated for posterior fossa tumors. Neuropsychology 2008;22(2):159–68.CrossRefGoogle ScholarPubMed
Stargatt, R, Rosenfeld, JV, Maixner, W, Ashley, D. Multiple factors contribute to neuropsychological outcome in children with posterior fossa tumors. Dev Neuropsychol 2007;32(2):729–48.CrossRefGoogle ScholarPubMed
Fuemmeler, BF, Elkin, TD, Mullins, LL. Survivors of childhood brain tumors: Behavioral, emotional, and social adjustment. Clin Psychol Rev 2002;22(4):547–86.CrossRefGoogle ScholarPubMed
Vannatta, K, Gerhardt, CA, Wells, RJ, Noll, RB. Intensity of CNS treatment for pediatric cancer: prediction of social outcomes in survivors. Pediatr Blood Cancer 2007;49(5):716–22.CrossRefGoogle ScholarPubMed
Barrera, M, Shaw, AK, Speechley, KN, Maunsell, E, Pogany, L. Educational and social late effects of childhood cancer and related clinical, personal, and familial characteristics. Cancer 2005;104(8):1751–60.CrossRefGoogle ScholarPubMed
Vannatta, K, Fairclough, F, Farkas-Patenaude, A, Gerhardt, C, Kupst, M, Olshefski, R, et al. Peer relationships of pediatric brain tumor survivors. Paper presented at 13th International Symposium on Pediatric Neuro-Oncology 2008.
Duffner, PK. Long-term effects of radiation therapy on cognitive and endocrine function in children with leukemia and brain tumors. Neurologist 2004;10(6):293–310.CrossRefGoogle ScholarPubMed
Mahone, EM, Slomine, B. Managing dysexecutive disorders. In Hunter, SJ, Donders, J, eds. Pediatric Neuropsychological Intervention: A Critical Review of Science and Practice. Cambridge: Cambridge University Press; 2007:314–37.Google Scholar
Barakat, LP, Hetzke, JD, Foley, B, Carey, ME, Gyato, K, Phillips, PC. Evaluation of a Social-Skills Training Group Intervention With Children Treated for Brain Tumors: A Pilot Study. J Pediatr Psychol 2003;28(5):299–307.CrossRefGoogle ScholarPubMed
Conklin, HM, Khan, R, Reddick, WE, Lawford, J, Howard, SC, Morris, B, et al. Medication for learning-impaired survivors of childhood cancer. Paper presented at 13th International Symposium on Pediatric Neuro-Oncology. 2008.
Conklin, HM, Khan, RB, Reddick, WE, Helton, S, Brown, R, Howard, SC, et al. Acute neurocognitive response to methylphenidate among survivors of childhood cancer: a randomized, double-blind, cross-over trial. J Pediat Psychol 2007;32(9):1127–39.CrossRefGoogle ScholarPubMed
Daly, BP, Brown, RT. Scholarly literature review: management of neurocognitive late effects with stimulant medication. J Pediatr Psychol 2007;32(9):1111–26.CrossRefGoogle ScholarPubMed
Thompson, SJ, Leigh, L, Christensen, R, Xiong, X, Kun, , Heideman, RL, et al. Immediate neurocognitive effects of methylphenidate on learning-impaired survivors of childhood cancer. J Clin Oncol 2001;19(6):1802–8.CrossRefGoogle ScholarPubMed
Butler, RW, Copeland, DR. Attentional processes and their remediation in children treated for cancer: a literature review and the development of a therapeutic approach. J Int Neuropsychol Soc 2002;8(1):115–24.CrossRefGoogle ScholarPubMed
Butler, RW, Copeland, DR, Fairclough, DL, Mulhern, RK, Katz, ER, Kazak, AE, et al. A multicenter, randomized clinical trial of a cognitive remediation program for childhood survivors of a pediatric malignancy. J Consult Clin Psychol 2008;76(3):367–78.CrossRefGoogle ScholarPubMed
Richards, GM, Khuntia, D, Mehta, MP. Therapeutic management of metastatic brain tumors. Crit Rev Oncol Hematol 2007;61(1):70–8.CrossRefGoogle ScholarPubMed
Tang, V, Rathbone, M, Park Dorsay, J, Jiang, S, Harvey, D. Rehabilitation in primary and metastatic brain tumours: impact of functional outcomes on survival. J Neurol 2008;255(6):820–7.CrossRefGoogle ScholarPubMed
Tucha, O, Smely, C, Preier, M, Lange, KW. Cognitive deficits before treatment among patients with brain tumors. Neurosurgery 2000;47(2):324.CrossRefGoogle ScholarPubMed
Taphoorn, MJ, Klein, M. Cognitive deficits in adult patients with brain tumours. Lancet Neurol 2004;3(3):159–68.CrossRefGoogle ScholarPubMed
Klein, M, Engelberts, NH, Ploeg, HM, Kasteleijn-Nolst Trenite, DG, Aaronson, NK, Taphoorn, MJ, et al. Epilepsy in low-grade gliomas: the impact on cognitive function and quality of life. Ann Neurol 2003;54(4):514–20.CrossRefGoogle ScholarPubMed
Armstrong, CL, Goldstein, B, Shera, D, Ledakis, GE, Tallent, EM. The predictive value of longitudinal neuropsychologic assessment in the early detection of brain tumor recurrence. Cancer 2003;97(3):649–56.CrossRefGoogle ScholarPubMed
Meyers, CA, Hess, KR. Multifaceted end points in brain tumor clinical trials: cognitive deterioration precedes MRI progression. Neuro-Oncology 2003;5(2):89–95.CrossRefGoogle ScholarPubMed
Meyers, CA, Hess, KR, Yung, WK, Levin, VA. Cognitive function as a predictor of survival in patients with recurrent malignant glioma. J Clin Oncol 2000;18(3):646–50.CrossRefGoogle ScholarPubMed
Gehring, K, Sitskoorn, MM, Aaronson, NK, Taphoorn, MJ. Interventions for cognitive deficits in adults with brain tumours. Lancet Neurol 2008;7(6):548–60.CrossRefGoogle ScholarPubMed
Meyers, CA, Weitzner, MA, Valentine, AD, Levin, VA. Methylphenidate therapy improves cognition, mood, and function of brain tumor patients. J Clin Oncol 1998;16(7):2522–7.CrossRefGoogle ScholarPubMed
Shaw, EG, Rosdhal, R, D'Agostino, RB, Jr., Lovato, J, Naughton, MJ, Robbins, ME, et al. Phase II study of donepezil in irradiated brain tumor patients: effect on cognitive function, mood, and quality of life. J Clin Oncol 2006;24(9):1415–20.CrossRefGoogle Scholar
Robertson, PL. Advances in treatment of pediatric brain tumors. NeuroRx 2006;3(2):276–91.CrossRefGoogle ScholarPubMed
Brouwers, P. Commentary: study of the neurobehavioral consequences of childhood cancer: entering the genomic era?J Pediatr Psychol 2005;30(1):79–84.CrossRefGoogle ScholarPubMed
McCarthy, BJ (Principal Investigator) CBTRUS. Specific Requested Analysis, 2000–2004 Data. Central Brain Tumor Registry of the United States, July 2008.
Ries, LAG, Melbert, D, Krapcho, M, Stinchcomb, DG, Howlader, N, Horner, MJ, et al. SEER Cancer Statistics Review, 1975–2005. 2008 (cited based on November 2007 SEER data submission posted to the SEER web site, 2008); Available from: http://seer.cancer.gov/csr/1975_2005.
Punt, JAG. Clinical syndromes. In Walker, DA, Perilongo, G, Punt, JAG, Taylor, RE, eds. Brain and Spinal Tumors of Childhood. London: Arnold; 2004: 99–106.CrossRefGoogle Scholar
Ullrich, NJ, Pomeroy, SL. Pediatric brain tumors. Neurol Clin 2003;21(4):897–913.CrossRefGoogle ScholarPubMed

Save book to Kindle

To save this book to your Kindle, first ensure coreplatform@cambridge.org is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.

Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.

Find out more about the Kindle Personal Document Service.

Available formats
×

Save book to Dropbox

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.

Available formats
×

Save book to Google Drive

To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.

Available formats
×